798 related articles for article (PubMed ID: 19434309)
21. The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
Popiela T; Kulig J; Kołodziejczyk P;
Przegl Lek; 2000; 57 Suppl 5():9-13. PubMed ID: 11202309
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with pN3 stage tumors according to the TNM classification in advanced gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Koabayashi N; Shimao H; Sakakibara Y; Kakita A
Hepatogastroenterology; 2003; 50(53):1723-6. PubMed ID: 14571827
[TBL] [Abstract][Full Text] [Related]
23. Is DNA aneuploidy a prognostic factor in gastric cancer?
Omejc M; Repse S; Bracko M
Acta Chir Hung; 1997; 36(1-4):266-9. PubMed ID: 9408370
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
[TBL] [Abstract][Full Text] [Related]
25. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
26. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer.
Hsu PI; Huang MS; Chen HC; Hsu PN; Lai TC; Wang JL; Lo GH; Lai KH; Tseng CJ; Hsiao M
J Surg Oncol; 2008 Jun; 97(7):609-14. PubMed ID: 18449914
[TBL] [Abstract][Full Text] [Related]
27. The mixed type in Laurén's classification of gastric carcinoma. Histologic description and biologic behavior.
Stelzner S; Emmrich P
Gen Diagn Pathol; 1997 Jul; 143(1):39-48. PubMed ID: 9269907
[TBL] [Abstract][Full Text] [Related]
28. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
[TBL] [Abstract][Full Text] [Related]
29. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
Gürbüz Y; Kahlke V; Klöppel G
Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic significance of the Lauren classification of patients with stomach carcinoma. A statistical analysis of long-term results following gastrectomy].
Roukos D; Lorenz M; Hottenrott C
Schweiz Med Wochenschr; 1989 May; 119(21):755-9. PubMed ID: 2756405
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic strategy for patients with pN0 gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
[TBL] [Abstract][Full Text] [Related]
33. [The study of the minimum number of examined lymph nodes for the TNM classification of gastric cancer].
Chen B; Sun JY; Jin F; Xu HM; Wang SB
Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):702-5. PubMed ID: 16008956
[TBL] [Abstract][Full Text] [Related]
34. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
[TBL] [Abstract][Full Text] [Related]
35. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer.
Zhao X; Huang K; Zhu Z; Chen S; Hu R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1317-21. PubMed ID: 17559372
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
37. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study.
Marrelli D; Roviello F; de Manzoni G; Morgagni P; Di Leo A; Saragoni L; De Stefano A; Folli S; Cordiano C; Pinto E;
World J Surg; 2002 Sep; 26(9):1160-5. PubMed ID: 12209247
[TBL] [Abstract][Full Text] [Related]
38. Gastric cancer histology: clinicopathologic characteristics and prognostic value.
Park JM; Jang YJ; Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS
J Surg Oncol; 2008 Dec; 98(7):520-5. PubMed ID: 18802956
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of bcl-2 expression in gastric cancer.
Müller W; Schneiders A; Hommel G; Gabbert HE
Anticancer Res; 1998; 18(6B):4699-704. PubMed ID: 9891543
[TBL] [Abstract][Full Text] [Related]
40. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
